11 Insiders Tip More Capital Into IN8BIO And Broker HC Wainwright Initiates With Bullish $14 Target
IN8BIO, Inc. (NASDAQ:INAB) topped the Fintel Significant Insider Buying Activity screen this week with 11 insiders buying over the last 90 days.
Stay updated with breaking news from Patrick Mccall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IN8BIO, Inc. (NASDAQ:INAB) topped the Fintel Significant Insider Buying Activity screen this week with 11 insiders buying over the last 90 days.
30.08.2022 - NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) - IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T cell therapies that utilize its DeltEx platform, today announced the ...
NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and...
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and...
Investegate announcements from ClarionDoor, LLC, Coaction Global Modernizes Product Distribution with ClarionDoor